NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1.40%1.4B | -9.49%526.2M | 1.69%404M | 33.49%304.9M | -5.11%161.6M | 59.16%1.38B | 63.87%581.4M | 44.89%397.3M | 22.60%228.4M | 239.92%170.3M |
Net income from continuing operations | 7.80%846.3M | 0.17%231.9M | 6.58%223.4M | 3.15%186.5M | 25.31%204.5M | 32.33%785.1M | 13.42%231.5M | 44.25%209.6M | 31.01%180.8M | 54.11%163.2M |
Operating gains losses | 159.76%63.9M | -111.24%-1M | -16.48%14.7M | 1,646.15%40.2M | 1,328.57%10M | 547.27%24.6M | 178.13%8.9M | 314.63%17.6M | -160.00%-2.6M | 40.00%700K |
Depreciation and amortization | 4.99%482M | 5.10%123.6M | 7.43%124.3M | 4.56%116.9M | 2.81%117.2M | 6.08%459.1M | 12.21%117.6M | 0.61%115.7M | 6.99%111.8M | 5.07%114M |
Deferred tax | 56.96%-33.1M | ---- | ---- | ---- | ---- | 10.37%-76.9M | ---- | ---- | ---- | ---- |
Other non cash items | -30.43%16M | 500.00%2M | 61.90%3.4M | -74.49%2.5M | -30.17%8.1M | -53.16%23M | -106.17%-500K | -93.98%2.1M | 415.79%9.8M | 176.19%11.6M |
Change In working capital | -146.20%-51.1M | -38.86%173.7M | -43.55%23.2M | 33.13%-55.7M | -46.46%-192.3M | 156.03%110.6M | 173.70%284.1M | 224.92%41.1M | -4.78%-83.3M | 30.46%-131.3M |
-Change in receivables | 7.20%-45.1M | -300.00%-27.2M | -2,060.00%-9.8M | -83.81%3.4M | 86.26%-11.5M | 75.10%-48.6M | 138.75%13.6M | 100.96%500K | 151.85%21M | -23.63%-83.7M |
-Change in inventory | -66.07%39.8M | -25.54%79.9M | -40.66%23.5M | -134.39%-5.4M | -28.48%-58.2M | 151.99%117.3M | 210.12%107.3M | 157.39%39.6M | 117.10%15.7M | 54.43%-45.3M |
-Change in payables and accrued expense | -129.90%-21.2M | -46.45%69.4M | 76.67%26.5M | 76.85%-13.8M | -632.62%-103.3M | -68.01%70.9M | 135.64%129.6M | -86.18%15M | -208.56%-59.6M | -540.63%-14.1M |
-Change in other working capital | 15.17%-24.6M | 53.57%51.6M | -21.43%-17M | 33.94%-39.9M | -263.56%-19.3M | -1,711.11%-29M | -31.85%33.6M | 31.71%-14M | -2,776.19%-60.4M | 147.39%11.8M |
Cash from discontinued investing activities | 0 | 0 | ||||||||
Operating cash flow | 1.40%1.4B | -9.49%526.2M | 1.69%404M | 33.49%304.9M | -5.11%161.6M | 60.11%1.38B | 63.91%581.4M | 44.84%397.3M | 23.26%228.4M | 270.22%170.3M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -193.04%-3.11B | -241.42%-234.9M | 88.49%-38.7M | -3,456.83%-2.63B | 64.64%-205.6M | -214.41%-1.06B | 68.41%-68.8M | -522.78%-336.3M | -327.17%-73.9M | -1,106.43%-581.5M |
Capital expenditure reported | -41.46%-149.1M | -19.26%-35.3M | -3.85%-29.7M | 12.10%-21.8M | -178.13%-62.3M | -11.42%-105.4M | 11.64%-29.6M | -31.19%-28.6M | -15.89%-24.8M | -25.14%-22.4M |
Net PPE purchase and sale | -19.74%6.1M | --0 | 1,933.33%6.1M | --0 | --0 | --7.6M | --0 | --300K | --0 | --7.3M |
Net business purchase and sale | -207.24%-2.96B | -409.18%-199.6M | 95.10%-15.1M | -5,164.57%-2.6B | 74.70%-143.3M | -290.19%-963M | 78.73%-39.2M | -856.52%-308M | ---49.4M | -1,769.31%-566.4M |
Net other investing changes | -2,100.00%-6M | --0 | --0 | ---- | ---- | -92.68%300K | --0 | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -193.04%-3.11B | -241.42%-234.9M | 88.49%-38.7M | -3,456.83%-2.63B | 64.64%-205.6M | -218.56%-1.06B | 68.41%-68.8M | -578.02%-336.3M | -327.17%-73.9M | -1,106.43%-581.5M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 605.93%1.71B | 47.67%-75.2M | -182.21%-79.3M | 2,641.36%1.94B | 10.86%-79.6M | 64.62%-337.5M | -648.44%-143.7M | -40.50%-28.1M | 90.43%-76.4M | 23.08%-89.3M |
Net issuance payments of debt | 7,542.75%2.05B | 87.50%-900K | -650.00%-1.1M | 21,592.71%2.06B | 35.45%-7.1M | 95.79%-27.6M | 15.29%-7.2M | 102.63%200K | 98.48%-9.6M | -14.58%-11M |
Net common stock issuance | 0.87%-260.7M | 51.96%-62.5M | -62,600.00%-62.7M | -12.19%-62.6M | 5.32%-72.9M | -0.73%-263M | -3,842.42%-130.1M | 97.56%-100K | 63.43%-55.8M | 23.84%-77M |
Cash dividends paid | 0.31%-32.3M | 0.00%-8.1M | 0.00%-8.1M | 1.23%-8M | 0.00%-8.1M | 0.00%-32.4M | 0.00%-8.1M | 0.00%-8.1M | -1.25%-8.1M | 1.22%-8.1M |
Proceeds from stock option exercised by employees | 6.27%32.2M | -53.57%3.9M | -11.11%5.6M | 79.69%11.5M | 21.74%11.2M | 56.99%30.3M | 82.61%8.4M | 0.00%6.3M | 68.42%6.4M | 100.00%9.2M |
Net other financing activities | -91.74%-85.9M | -310.45%-27.5M | 126.14%6.9M | -573.12%-62.6M | -12.50%-2.7M | -85.12%-44.8M | 61.27%-6.7M | -482.61%-26.4M | 22.50%-9.3M | -33.33%-2.4M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 605.93%1.71B | 47.67%-75.2M | -182.21%-79.3M | 2,641.36%1.94B | 10.86%-79.6M | 64.62%-337.5M | -648.44%-143.7M | -40.50%-28.1M | 90.43%-76.4M | 23.08%-89.3M |
Net cash flow | ||||||||||
Beginning cash position | -1.08%1.6B | 14.98%1.38B | -9.81%1.06B | 29.75%1.45B | -1.08%1.6B | -23.54%1.61B | -17.95%1.2B | -10.01%1.18B | -43.76%1.12B | -23.54%1.61B |
Current changes in cash | 83.01%-3.5M | -41.42%216.1M | 769.30%286M | -589.12%-382M | 75.30%-123.6M | 95.17%-20.6M | 213.42%368.9M | -83.94%32.9M | 112.38%78.1M | -323.08%-500.5M |
Effect of exchange rate changes | -1,738.71%-50.8M | -278.01%-51.8M | 310.37%28.4M | 59.59%-7.8M | -388.24%-19.6M | 104.43%3.1M | -18.72%29.1M | 75.27%-13.5M | 61.48%-19.3M | 718.18%6.8M |
End cash Position | -3.40%1.54B | -3.40%1.54B | 14.98%1.38B | -9.81%1.06B | 29.75%1.45B | -1.08%1.6B | -1.08%1.6B | -17.95%1.2B | -10.01%1.18B | -43.76%1.12B |
Free cash flow | -1.92%1.25B | -11.04%490.9M | 1.52%374.3M | 39.05%283.1M | -32.86%99.3M | 66.12%1.27B | 71.79%551.8M | 46.02%368.7M | 24.22%203.6M | 426.33%147.9M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |